The Ballarat Base Hospital is a hospital located in Ballarat, Victoria, Australia. It is a public hospital operated by Ballarat Health Services.

There are 785 beds in Ballarat Health Services.

During the past decade, Ballarat Health Services conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 15 clinical trials were completed, i.e. on average, 34.9% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 12 clinical trials were completed. i.e. 92.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ballarat Health Services" #1 sponsor was "Celgene" with 5 trials, followed by "EMD Serono Research & Development Institute, Inc." with 4 trials sponsored, "Australian and New Zealand Intensive Care Research Centre" with 3 trials sponsored, "Takeda" with 3 trials sponsored and "Austin Health" with 3 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ballarat Health Services" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "National Health and Medical Research Council, Australia" with 3 trials as a collaborator, "Ballarat Health Services" with 2 trials as a collaborator and "Baxter Healthcare Corporation" with 2 trials as a collaborator. Other collaborators include 42 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "Ballarat Health Services" are "Crohn Disease" (5 trials), "Crohn's Disease" (3 trials), "Follicular Lymphoma" (3 trials), "Colitis, Ulcerative" (2 trials) and "Critically Ill" (2 trials). Many other conditions were trialed in "Ballarat Health Services" in a lesser frequency.

Most popular intervention types in "Ballarat Health Services" are "Drug" (43 trials), "Other" (11 trials), "Biological" (4 trials), "Dietary Supplement" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Avelumab" (5 trials), "Docetaxel" (3 trials), "Nivolumab" (3 trials) and "Ozanimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ballarat Health Services" are 47 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ballarat Health Services". undefined are not yet recruiting, 12 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 19 completed trials in Ballarat Health Services, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ballarat Health Services, 3 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".

Ballarat Health Services has several departments that took part in Clinical trials: "Ballarat Regional Integrated Cancer Centre" - 2 trials